Medical research

Resistance-fighting antimalarial drug candidate enters the clinic

A new antimalarial drug candidate, discovered through a longstanding collaboration between WEHI and global biopharmaceutical company MSD has entered Phase 1 clinical testing in healthy participants. The candidate drug inhibits ...

Medical research

Researchers discover key pathway for COVID organ damage in adults

Even after three years since the emergence of COVID-19, much remains unknown about how it causes severe disease, including the widespread organ damage beyond just the lungs. Increasingly, scientists are learning that organ ...

Diseases, Conditions, Syndromes

A two-pronged approach to target critical malaria protein

A protein that plays a critical role in helping malaria parasites infect red blood cells—known as apical membrane protein 1 (AMA1)—has been found to bind to more than one receptor on the surface of the cells.

page 10 from 40